Cellectar Biosciences logo

Cellectar Biosciences Share Price (NASDAQ: CLRB)

$4.81

-0.07

(-1.43%)

Live

Last updated on

Check the interactive Cellectar Biosciences Stock chart to analyse performance

Cellectar Biosciences stock performance

as on August 26, 2025 at 12:37 AM IST

  • Today's Low:$4.72
    Today's High:$4.86

    Day's Volatility :2.88%

  • 52 Weeks Low:$4.11
    52 Weeks High:$68.70

    52 Weeks Volatility :94.02%

Cellectar Biosciences Stock Returns

PeriodCellectar Biosciences IncIndex (Russel 2000)
3 Months
-35.68%
0.0%
6 Months
-44.48%
0.0%
1 Year
-92.5%
0.0%
3 Years
-96.95%
-10.0%

Cellectar Biosciences Inc Key Stats

Check Cellectar Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.88
Open
$4.68
Today's High
$4.86
Today's Low
$4.6
Market Capitalization
$15.6M
Today's Volume
$66.9K
52 Week High
$68.7
52 Week Low
$4.11
Revenue TTM
$0.0
EBITDA
$-38.3M
Earnings Per Share (EPS)
$-24.28
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-273.88%

Stock Returns calculator for Cellectar Biosciences Stock including INR - Dollar returns

The Cellectar Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cellectar Biosciences investment value today

Current value as on today

₹11,724

Returns

₹88,276

(-88.28%)

Returns from Cellectar Biosciences Stock

₹92,611 (-92.61%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Cellectar Biosciences Stock

-73%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Cellectar Biosciences Stock from India on INDmoney has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cellectar Biosciences Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    1.97%

  • UBS Group AG

    1.07%

  • Geode Capital Management, LLC

    0.52%

  • Squarepoint Ops LLC

    0.43%

  • Citadel Advisors Llc

    0.40%

  • BlackRock Inc

    0.27%

Analyst Recommendation on Cellectar Biosciences Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cellectar Biosciences(by analysts ranked 0 to 5 stars)

Cellectar Biosciences Share Price Target

What analysts predicted

Upside of 877.13%

Target:

$47.00

Current:

$4.81

Cellectar Biosciences share price target is $47.00, a slight Upside of 877.13% compared to current price of $4.81 as per analysts' prediction.

Cellectar Biosciences Stock Insights

  • Price Movement

    In the last 3 months, CLRB stock has moved down by -34.7%
  • CLRB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 159.0%
  • CLRB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 209.4%

Cellectar Biosciences Technicals Summary

Sell

Neutral

Buy

Cellectar Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cellectar Biosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cellectar Biosciences Inc logo
-2.98%
-44.48%
-92.5%
-96.95%
-98.68%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Cellectar Biosciences Inc

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Organization
Cellectar Biosciences
Employees
11
CEO
Mr. James V. Caruso
Industry
Health Technology

Key Management of Cellectar Biosciences Inc

NameTitle
Mr. James V. Caruso
President, CEO & Director
Mr. Chad J. Kolean CPA
VP, CFO & Secretary
Mr. Jarrod Longcor
Chief Operating Officer

Important FAQs about investing in CLRB Stock from India :

What is Cellectar Biosciences share price today?

Cellectar Biosciences share price today is $4.81 as on . Cellectar Biosciences share today touched a day high of $4.86 and a low of $4.72.

What is the 52 week high and 52 week low for Cellectar Biosciences share?

Cellectar Biosciences share touched a 52 week high of $68.70 and a 52 week low of $4.11. Cellectar Biosciences stock price today i.e. is trending at $4.81, lower by 93% versus the 52 week high.

How to invest in Cellectar Biosciences Stock (CLRB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cellectar Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellectar Biosciences Shares that will get you 0.3119 shares as per Cellectar Biosciences share price of $4.81 per share as on August 26, 2025 at 12:37 AM IST.

What is the minimum amount required to buy Cellectar Biosciences Stock (CLRB) from India?

Indian investors can start investing in Cellectar Biosciences (CLRB) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Cellectar Biosciences stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Cellectar Biosciences share’s latest price of $4.81 as on August 26, 2025 at 12:37 AM IST, you will get 2.0790 shares of Cellectar Biosciences. Learn more about fractional shares .

What are the returns that Cellectar Biosciences has given to Indian investors in the last 5 years?

Cellectar Biosciences stock has given -98.68% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?